in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pfizer walks away from AstraZeneca bid
1:41 PM MDT | May 27, 2014 | Natasha Alperowicz
Pfizer confirmed today that its “informal” offer to acquire AstraZeneca for £69.4 billion (117 billion) has lapsed and that it was consequently withdrawing the offer. This decision follows the expiry, at 5:00 pm BST, of a 28-day “put up or shut up” deadline under UK takeover rules by which Pfizer was required to make a firm offer to AstraZeneca shareholders. Pfizer made an “informal” but “final” offer of £55/share in cash and Pfizer shares on 19 May for AstraZeneca; that offer was rejected by the UK...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee